Bharat Biotech today announced that BBV152 (Covaxin), its whole-virion inactivated Covid-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.
Bharat Biotech had…
The Drug Controller General of India (DCGI) on Saturday approved Covaxin for emergency use for children above 12 years. The approval is for children between 12 to 18 years of age only. The vaccine is not for children below 12 years.
…
An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions, sources said on Tuesday.
